UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment Journal article
Deng, Chao, Li, Zi Xi, Xie, Chen Jun, Zhang, Qing Lin, Hu, Ben Shun, Wang, Mei Dan, Mei, Jie, Yang, Chen, Zhong, Zhangfeng, Wang, Ke Wei. Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment[J]. Human Genomics, 2024, 18(1), 55.
Authors:  Deng, Chao;  Li, Zi Xi;  Xie, Chen Jun;  Zhang, Qing Lin;  Hu, Ben Shun; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.8/4.0 | Submit date:2024/07/04
Cdkn2a  Immune Checkpoint Inhibitor  Immunotherapy  Pan-cancer  
Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer Journal article
Sun, Yidan, Yang, Xinyu, Ren, Shiqi, Lu, Zhichao, Liu, Zongheng, Kong, Fanming, Wang, Ziheng, Yang, Yang. Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer[J]. Journal of Men's Health, 2023, 19(11), 16-33.
Authors:  Sun, Yidan;  Yang, Xinyu;  Ren, Shiqi;  Lu, Zhichao;  Liu, Zongheng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:0.6/0.6 | Submit date:2024/01/10
Immune Checkpoint Inhibitor  Immunotherapy  Prognostic Model  Prostate Cancer  Tumor Immune Microenvironment